Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|June 3, 1998
[Chimeric hepatitis B core antigen particles as a presentation system of foreign protein epitopes]L I Karpenko, A A Il'ichevZhurnal Mikrobiologii, Epidemiologii I Immunobiologii|May 24, 2011
[MHC-multimers and their application in studies of antiviral immune response]L I Karpenko, L V Mechetina, A Iu ReguzovaVavilovskii Zhurnal Genetiki I Selektsii|May 7, 2021
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine developmentA A Ilyichev, L A Orlova, S V Sharabrin, et al.Russian Journal of Bioorganic Chemistry|May 30, 2023
mRNA Vaccine Platform: mRNA Production and DeliveryV R Litvinova, A P Rudometov, L I Karpenko, et al.Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|September 7, 2000
[Construction of original artificial immunogens--candidate vaccines against HIV-1]L R Lebedev, I P Gileva, L I Karpenko, et al.Acta Naturae|January 23, 2016
Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune ResponseD N Shcherbakov, A Y Bakulina, L I Karpenko, et al.Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|June 19, 2012
[The impact of the antibody 2F5 biotinylation on the selection of the peptides from combinatorial phage library]N S Shcherbakova, A N Chikaev, L I Karpenko, et al.Voprosy Virusologii|March 7, 2007
[Humoral immune response of BALB/c mice immunized with chimer HBcAg proteins carrying the epitopes of surface hepatic B virus protein]T A Veremeĭko, L R Lebedev, N A Chikaev, et al.Vavilovskii Zhurnal Genetiki I Selektsii|October 1, 2021
Phage display as a tool for identifying HIV-1 broadly neutralizing antibodiesA N Chikaev, A N Chikaev, A P Rudometov, et al.Vavilovskii Zhurnal Genetiki I Selektsii|April 18, 2022
Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1N B Rudometova, D N Shcherbakov, A P Rudometov, et al.Pageof 6